Template:Congestive heart failure: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Congestive heart failure risk factors|Risk Factors]]
[[Congestive heart failure causes|Causes of Congestive heart failure]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Congestive heart failure causes|Causes of Congestive heart failure]]
[[Congestive heart failure risk factors|Risk Factors]]
|-  
|-  
!
!
Line 118: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Congestive heart failure other diagnostic studies|Other Diagnostic Studies]]
[[Congestive heart failure exercise stress testing|Exercise Stress Test]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Congestive heart failure myocardial viability study|Myocardial Viability Studies]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Congestive heart failure cardiac catheterization|Cardiac Catheterization]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Congestive heart failure endomyocardial biopsy|Endomyocardial biopsy]]
|-  
|-  
!
!
Line 125: Line 143:
!
!
Treatment
Treatment
|-
!
|- bgcolor="PaleTurquoise"
!
[[Congestive heart failure invasive monitoring|Invasive Hemodynamic Monitoring]]
|-  
|-  
!
!
Line 134: Line 158:
: Chronic Pharmacotherapy:
: Chronic Pharmacotherapy:
:: [[Congestive heart failure diuretics|Diuretics]]
:: [[Congestive heart failure diuretics|Diuretics]]
:: [[Congestive heart failure renin angiotensin aldosterone axis inhibitors|Renin-Angiotensin-Aldosterone Axis Inhibitors]]
:: [[Congestive heart failure ACE inhibitors or angiotensin receptor blockers|ACE Inhibitors]]
:: [[Congestive heart failure nitrates|Nitrates]]
:: [[Congestive heart failure ACE inhibitors or angiotensin receptor blockers|Angiotensin receptor blockers]]
:: [[Congestive heart failure anticoagulants|Anticoagulants]]
:: [[Congestive heart failure aldosterone antagonists|Aldosterone Antagonists]]
:: [[Congestive heart failure beta blockers|Beta Blockers]]
:: [[Congestive heart failure beta blockers|Beta Blockers]]
:: [[Congestive heart failure antiarrhythmic drugs|Antiarrhythmic Drugs]]
:: [[Congestive heart failure calcium channel blockers|Ca Channel Blockers]]
:: [[Congestive heart failure vasodilators|Nitrates]]
:: [[Congestive heart failure vasodilators|Hydralazine]]
:: [[Congestive heart failure positive inotropics|Positive Inotropics]]
:: [[Congestive heart failure positive inotropics|Positive Inotropics]]
:: [[Congestive heart failure metformin|Metformin]]
:: [[Congestive heart failure anticoagulants|Anticoagulants]]
:: [[Congestive heart failure calcium channel blockers|Ca Channel Blockers]]
:: [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]]
:: [[Congestive heart failure other pharmacotherapies#Metformin|Metformin]]
:: [[Congestive heart failure other pharmacotherapies#Nutritional Supplements|Nutritional Supplements]]
:: [[Congestive heart failure other pharmacotherapies#Hormonal Therapies|Hormonal Therapies]]
|-
!
 
|- bgcolor="PaleTurquoise"
!
[[Congestive heart failure and exercise|Exercise Training]]
|-  
|-  
!
!
Line 147: Line 182:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Surgery:
Surgical Therapy:
: [[Congestive heart failure biventricular pacing or cardiac resynchronization therapy|Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)]]
: [[Congestive heart failure biventricular pacing or cardiac resynchronization therapy|Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)]]
: [[Congestive heart failure implantation of intracardiac defibrillator|Implantation of Intracardiac Defibrillator]]
: [[Congestive heart failure implantation of intracardiac defibrillator|Implantation of Intracardiac Defibrillator]]
Line 155: Line 190:
: [[Congestive heart failure cardiac transplantation|Cardiac Transplantation]]
: [[Congestive heart failure cardiac transplantation|Cardiac Transplantation]]
: [[Congestive heart failure cardiac surgery|Cardiac Surgery]]
: [[Congestive heart failure cardiac surgery|Cardiac Surgery]]
: [[Congestive heart failure invasive monitoring|Invasive Monitoring]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Congestive heart failure discharge care|Discharge Care]]
|-  
|-  
!
!
Line 167: Line 195:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Guideline Recommendations
ACC/AHA Guideline Recommendations:


: [[Congestive heart failure AHA recommendations for hospitalized patient|Hospitalized Patients]]
: [[Congestive heart failure AHA recommendations for hospitalized patient|Hospitalized Patients]]

Revision as of 16:59, 6 April 2012

Congestive heart failure Microchapters

Home

Patient Info

Overview

Classification

Pathophysiology

Epidemiology & Demographics

Causes of Congestive heart failure

Risk Factors

Differentiating Congestive heart failure from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Clinical Assessment

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

Echocardiography

Exercise Stress Test

Myocardial Viability Studies

Cardiac Catheterization

Endomyocardial biopsy

Treatment

Invasive Hemodynamic Monitoring

Medical Therapy:

Acute Pharmacotherapy
Chronic Pharmacotherapy:
Diuretics
ACE Inhibitors
Angiotensin receptor blockers
Aldosterone Antagonists
Beta Blockers
Ca Channel Blockers
Nitrates
Hydralazine
Positive Inotropics
Anticoagulants
Antiarrhythmic Drugs
Metformin
Nutritional Supplements
Hormonal Therapies

Exercise Training

Surgical Therapy:

Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)
Implantation of Intracardiac Defibrillator
Ultrafiltration
Cardiac Surgery
Left Ventricular Assist Devices (LVADs)
Cardiac Transplantation
Cardiac Surgery

ACC/AHA Guideline Recommendations:

Hospitalized Patients
Patients at high risk for developing heart failure (Stage A)
Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
Patients with current or prior symptoms of heart failure (Stage C)
Patients with refractory end-stage heart failure (Stage D)

Implementation of Practice Guidelines

Congestive heart failure end-of-life considerations

Specific Groups:

Special Populations
Patients who have concomitant disorders
Obstructive Sleep Apnea in the Patient with CHF

Congestive heart failure On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congestive heart failure

CDC on Congestive heart failure

Congestive heart failure in the news

Blogs on Congestive heart failure

Directions to Hospitals Treating Congestive heart failure

Risk calculators and risk factors for Congestive heart failure